Patents Examined by Richard Wagner
-
Patent number: 4960690Abstract: Nucleic acid hybridizaiton probes are provided which have sequences complementary to sequences of segments in bovine male-specific DNA and are suitable for sexing bovine embryos at the time of embryo transfer with nearly 100% accuracy.Type: GrantFiled: June 5, 1986Date of Patent: October 2, 1990Assignee: The Salk Institute Biotechnology Industrial Associates, Inc.Inventors: Steven B. Ellis, Michael M. Harpold
-
Patent number: 4925652Abstract: Diagnostic media suitable for NMR diagnoses contain compounds of Formula I ##STR1## wherein is a single bond or a double bond,X is the grouping --(CH.sub.2).sub.n -- or , if is a single bond, also the grouping --NHCO(CH.sub.2).sub.n -- wherein n means 0 to 4,m means the numbers 0, 1, or 2,R.sub.1 is an alkyl residue substituted by hydroxy groups, acyloxy groups and/or alkylidenedioxy groups,R.sub.2 has the same meanings as R.sub.1 or is a hydrogen atom or an alkyl residue,R.sub.3 and R.sub.4 are alkyl residues, andR.sub.5 and R.sub.6 are alkyl residues optionally substituted by hydroxy groups.Type: GrantFiled: August 3, 1984Date of Patent: May 15, 1990Assignee: Schering AktiengesellschaftInventors: Heinz Gries, Ulrich Niedballa, Hanns-Joachim Weinmann
-
Patent number: 4920063Abstract: Methods and associated devices for detecting the presence of a particular motile organism within a sample are disclosed. The sample may be derived from dry milk, raw meat, poultry or a clinical specimen. A preferred method includes inoculating a selective enrichment medium containing a chemotactic attractant with the sample and contacting the selective enrichment medium with a nonselective motility medium containing a chemotatic attractant in a concentration less than the attractant concentration in the selective enrichment medium. Upon incubation, the motile organism metabolizes the chemotactic attractant, allowing the organism to move into the motility medium where it interacts with antibodies specific for the organism, thereby causing the formation of a persistent immobilization band. The methods are particularly useful in detecting Salmonella.Type: GrantFiled: September 9, 1985Date of Patent: April 24, 1990Assignee: BioControl Systems, Inc.Inventor: N. Robert Ward, Jr.
-
Patent number: 4913853Abstract: Water soluble, substantially nontoxic salts of compounds of the formula:CF.sub.3 Rwherein R is --SO.sub.3 H, --SO.sub.2 NH.sub.2 or --PO.sub.3 H.sub.2, are useful for obtaining fluorine magnetic resonance images of body organs and tissues. Illustrative salts of such compounds include sodium trifluoromethane sulfonate, N-methylglucaminium trifluoromethanesulfonate and N-methylglucaminium trifluoromethanesulfonamide.Type: GrantFiled: December 10, 1986Date of Patent: April 3, 1990Assignee: Mallinckrodt, Inc.Inventor: George B. Hoey
-
Patent number: 4912032Abstract: Methods for delivering substances into, removing substances from, or reacting substances with a selected environment utilizing polymer gels or coatings characterized by a critical solution temperature (CST) are disclosed. The CST as well as the pore structure, pore size, pore distribution, and absorbing capacity of the gel may be selectively controlled. The substances may be physically or chemically immobilized within the polymer gels. In addition, a method for altering the surface wettability of CST polymers is also disclosed.Type: GrantFiled: December 31, 1986Date of Patent: March 27, 1990Assignee: Genetec Systems CorporationInventors: Allan S. Hoffman, Nobuo Monji
-
Patent number: 4900662Abstract: Methods and reagents for early detection of myocardial infarction determine the level of CK-MM.sub.A and the level of the combined CK-MM.sub.A and CK-MM.sub.B in a serum sample. From these measurements, the time of the acute phase can be more accurately determined. Novel anti-(CK-MM.sub.A) antibodies, anti-(CK-MM.sub.B) antibodies, anti-(CK-MM.sub.(A+B)) antibodies, labeled and insolubilized derivatives of these antibodies, labeled CK-MM isoforms, and kits containing one or more of these reagents are also described.Type: GrantFiled: July 21, 1987Date of Patent: February 13, 1990Assignee: International Immunoassay Laboratories, Inc.Inventors: Vipin D. Shah, Shing-Erh Yen, Gerald M. Anchin
-
Patent number: 4897345Abstract: This invention provides an immunologic method for measuring plant pollen germination and pollen tube growth. This method is based on the finding that an antibody having specificity to .beta.-L-arabinofuranosyl residues binds to the surface of in vitro grown pollen tubes. Antibody binding can be measured qualitatively or quantitatively using a calibration curve. The immunoassay is useful for screening plants for response to substances that affect plant germination or pollen tube growth.Type: GrantFiled: July 20, 1987Date of Patent: January 30, 1990Assignee: Lubrizol Genetics Inc.Inventors: Philip J. Harris, Marilyn A. Anderson, Adrienne E. Clarke
-
Patent number: 4895795Abstract: Methods for detecting the presence of Coxiella burenetii in biological samples, as well as a method for differentiating strains of C. burnetii that are capable of causing acute disease from those strains capable of causing chronic disease are disclosed. The methods generally comprise treating cells contained within the biological sample to expose cellular DNA, and hybridizing the cellular DNA (specifically rickettsial DNA) with a C. burnetii-specific labeled DNA probe. Radioisotope and biotin labels are preferred, allowing detection through autoradiography and colorimetric assays, respectively.Type: GrantFiled: November 5, 1986Date of Patent: January 23, 1990Assignee: Battelle Development CorporationInventors: Marvin E. Frazier, Louis P. Mallavia, James E. Samuel, Oswald G. Baca
-
Patent number: 4888278Abstract: Improved methodologies for in-situ hybridization and detection of hybridized nucleic acid sequences in cell cultures and tissue sections are provided which offer an increase of speed, sensitivity, and simplicity unavailable in previously known techniques. The invention detects specific nucleic acids of interest, particularly RNA sequences, within cells and tissues utilizing DNA of a particular size as a probe to find those sequences which are held substantially in common between the cell or tissue and the probe. The cells are fixed preferably in paraformaldehyde and then hybridized using a hybridization fluid for not less than 10 minutes but not substantially more than 24 hours. A variety of identifying labels are attached to the probe which permit quick and rapid detection via measurement of radioactive isotope decay or by colorimetric detection of enzymatic reaction products.Type: GrantFiled: October 13, 1988Date of Patent: December 19, 1989Assignee: University of Massachusetts Medical CenterInventors: Robert H. Singer, Jeanne B. Lawrence
-
Patent number: 4886740Abstract: A membrane for an enzyme-electrode type sensor treated to increase the range of linearity of the sensor response.Type: GrantFiled: May 28, 1986Date of Patent: December 12, 1989Assignee: Imperial Chemical Industries PLCInventor: Pankaj M. Vadgama
-
Patent number: 4885237Abstract: A method is described for the detection of halodeoxyuridines taken up by cells during DNA synthesis by the use of monoclonal antibodies. The described method also allows the simultaneous detection of cell surface receptors.Type: GrantFiled: June 6, 1988Date of Patent: December 5, 1989Assignee: Becton, Dickinson and CompanyInventors: Elizabeth L. Evans, Nick J. Gonchoroff, Philip R. Greipp, David W. Houck, Jerry A. Katzmann, Robert A. Kyle, Michael R. Loken
-
Patent number: 4876186Abstract: Methods for detecting the presence of Coxiella burnetii in biological samples, as well as a method for differentiating strains of C. burnetii that are capable of causing acute disease from those strains capable of causing chronic disease are disclosed. The methods generally comprise treating cells contained within the biological sample to expose cellular DNA, and hybridizing the cellular DNA (specifically rickettsial DNA) with a C. burnetii-specific labeled DNA probe. Radioisotope and biotin labels are preferred, allowing detection through autoradiography and colorimetric assays, respectively.Type: GrantFiled: November 5, 1985Date of Patent: October 24, 1989Assignee: Battelle Development CorporationInventors: Marvin E. Frazier, Louis P. Mallavia, Oswald G. Baca, James E. Samuel
-
Patent number: 4871660Abstract: Luminescence immuno-test kits consist of an antigen or antibody capable of showing luminescence and labelled with phthalic hydrazides, an antibody or antigen preferably bound to a carrier and an oxidizing reagent inducing the luminescence to occur and are characterized in that the oxidizing reagent is a pre-fabricated solution of catalase, optionally stabilized by a bacteriostat, and the initiator is a pre-fabricated peroxide solution which is at least 20 minutes old. These luminescence immuno-tests are particularly stable and may be subjected to a quality control in a simple and inexpensive way.Type: GrantFiled: March 11, 1987Date of Patent: October 3, 1989Assignee: Henning Berlin GmbHInventor: Andre Gadow
-
Patent number: 4868104Abstract: A method for determining the presence of a polynucleotide analyte in a sample suspected of containing the analyte is disclosed. The method comprises combining in an assay medium the sample and first and second polynucleotide reagents complementary to the analyte. Each of the first and second reagents hybridize with a different region of the analyte. The first reagent contains means for rendering the first reagent non-covalently polymerizable. The second reagent contains means for rendering the second reagent detectable. The sample and the first and second reagents are combined in the assay medium under conditions for polymerizing the first reagent wherein the second reagent becomes bound to the polymerized first reagent only when the analyte is present in the sample. A determination is then made as to whether the second reagent has become bound to the polymerized first reagent.Type: GrantFiled: September 6, 1985Date of Patent: September 19, 1989Assignee: Syntex (U.S.A.) Inc.Inventors: Nurith Kurn, Chander Bahl, Edwin F. Ullman
-
Patent number: 4861708Abstract: Polymorphisms in the renin, kallikrein, and ANF gene regions are predictive for hypertension in individual human subjects.Type: GrantFiled: January 9, 1986Date of Patent: August 29, 1989Assignee: California Biotechnology Inc.Inventor: Philippe M. Frossard
-
Patent number: 4861728Abstract: A method for determining the percentage of glycosylated hemoglobin in the total hemoglobin of a blood sample includes binding of both glycosylated and nonglycosylated hemoglobin competitively to a nonspecific binder for hemoglobin affixed to a dipstick and reacting the glycosylated hemoglobin with a dihydroxyboryl reagent conjugated to a fluorescent dye. When the binding and reacting steps are complete, the dipstick is washed and its color is measured by absorption of incident light having a wavelength within the absorption range of hemoglobin as an indication of total hemoglobin in the sample. Incident light having a wavelength within the absorption range of the dye is then applied to the dipstick and fluorescence from the dipstick is measured as an indication of glycosylated hemoglobin. The measurements may be made with a reflectometer capable of computing the percentage of glycosylated hemoglobin in the sample from the color and fluorescence measurements.Type: GrantFiled: July 24, 1987Date of Patent: August 29, 1989Assignee: Becton, Dickinson and CompanyInventor: Daniel B. Wagner
-
Patent number: 4859609Abstract: Hybrid receptors are provided that comprise (a) the ligand binding domain of a predetermined receptor and (b) a heterologous reporter polypeptide. The hybrid receptors are useful for convenient and large scale assay of biologically active ligands or their antagonists or agonists.Type: GrantFiled: April 30, 1986Date of Patent: August 22, 1989Assignee: Genentech, Inc.Inventors: Thomas J. Dull, Heimo Riedel, Axel Ullrich
-
Patent number: 4849507Abstract: A compound essentially free of compounds of molecular weight above 10,000, the compound characterized in that it is water soluble, it has a molecular weight between about 1,000 and 10,000, it suppresses immunoglobulin synthesis in pokeweed mitogen-stimulated human lymphocytes, it does not inhibit proliferation of human lymphocytes induced by concanavalin A or pokeweed mitogen, it inhibits phytohemmaglutinin-induced proliferation of human T4 cells, and it inhibits IL-2 production of human T4 cells.Type: GrantFiled: February 28, 1986Date of Patent: July 18, 1989Inventor: Martha K. Cathcart
-
Patent number: 4839279Abstract: A novel enzyme of bilirubin oxidase and a conventional enzyme of laccase are found to oxidize bilirubin to biliverdin without formation of hydrogen peroxide, thereby permitting the content of conjugated bilirubin in biological fluid to be quantitatively determined by reacting therewith the bilirubin oxidase of a microorganism of genus Myrothecium origin, and also permitting the content of total bilirubin in biological fluid to be quantitatively determined by reacting therewith such a bilirubin oxidase or laccase in the presence of a specific additive compound.Type: GrantFiled: June 27, 1985Date of Patent: June 13, 1989Assignee: Amano Pharmaceutical Co., Ltd.Inventors: Akira Kosaka, Sawao Murao, Kenichi Hirano, Noriaki Tanaka, Kuniyoshi Matsunaga
-
Patent number: 4834976Abstract: Cell lines have been produced that secrete monoclonal antibodies capable of binding to the flagellar proteins of selected Pseudomonas aeruginosa strains. Some of these antibodies have been found to be protective against lethal challenges of P. aeruginosa. Pharmaceutical compositions containing these antibodies, which can be in combination with other monoclonal antibodies, blood plasma fractions and antimicrobial agents, and the prophylactic and therapeutic use of such compositions in the management of infections, are included.Prior to filing this application, the continuous transformed cell lines PaF4 IVE8, FA6 IIG5, 20H11, and 21B8, described herein, were deposited in the America Type Culture Collection and given the designations HB9129, HB9130, CRL 9300, and CRL 9301, respectively.Type: GrantFiled: December 24, 1986Date of Patent: May 30, 1989Assignee: Genetic Systems CorporationInventors: Mae J. Rosok, Mark E. Lostrom